Bio-Techne (TECH) EBT Margin (2009 - 2026)

Bio-Techne's EBT Margin history runs 18 years deep, the most recent figure standing at 22.87% for Q1 2026.

• In Q1 2026, EBT Margin rose 1077.0% year-over-year to 22.87%; the TTM figure through Mar 2026 stood at 4.98% (down 760.0% YoY), while the FY2025 annual figure was 0.96%, down 1413.0% from the prior year.
• EBT Margin for Q1 2026 stood at 22.87%, up from 17.16% in the prior quarter.
• The five-year high for EBT Margin was 5185.8% in Q3 2022, with the low at 34.6% in Q2 2025.
• The 5-year median for EBT Margin is 17.9% (2023), against an average of 320.05%.
• The sharpest annual moves came in 2022 and 2023: EBT Margin surged 515965 bps in 2022, then plunged 516790 bps in 2023.
• Bio-Techne's EBT Margin stood at 24.46% in 2022, then plunged by 50 bps to 12.25% in 2023, then climbed by 18 bps to 14.43% in 2024, then gained by 19 bps to 17.16% in 2025, then soared by 33 bps to 22.87% in 2026.
• Business Quant data shows TECH's EBT Margin at 22.87% in Q1 2026, 17.16% in Q4 2025, and 16.75% in Q3 2025.